Navigation Links
Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy
Date:4/24/2013

HERSHEY, Pa. and ROCKVILLE, Md., April 24, 2013 /PRNewswire/ -- Immunomic Therapeutics, Inc., ("ITI," Hershey, PA), a leading developer of novel allergy immunotherapies, announced the preliminary results of a Phase I Study to treat individuals with an allergy to Japanese red cedar ("JRC").  The Company is pleased to report that the immunotherapeutic vaccine, JRC-LAMP-vax™, appears to have met all of its primary safety end points.  In addition, preliminary allergic marker results indicate a favorable trend in resolving the allergy.

Within the three subject sub-groups, (24 total patients) there were no reports of any Severe Adverse Events (SAE).  A small number of mild adverse events were reported in about 10% of the vaccinations, generally related to soreness associated with the intra-muscular injection.  The safety results are consistent with other clinical studies that have incorporated LAMP, which also showed the vaccine to be safe and well tolerated.  In addition to monitoring vaccine safety, subjects were also evaluated for immunological markers of allergy including circulating IgE, immunoglobulin G (IgG) and skin test reactivity. 

At the 2013 BIO International Convention, the CEO of Immunomic Therapeutics, Dr. William Hearl , presented the preliminary data for cedar specific IgE and for skin test reactivity.  All patients had stable IgE levels including those patients who entered the study as non-allergic to JRC.  This observation indicates that the vaccine does not induce a new IgE antibody response in either naive or allergic subjects.

Skin testing is perhaps the oldest and most reliable form of allergy testing.  Skin testing has been performed for 100 years and continues to be the test of choice for the diagnosis of allergic disease.  A number of the subject
'/>"/>

SOURCE Immunomic Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Immunomic Therapeutics Begins Phase I Japanese Red Cedar JRC-LAMP-Vax Vaccine Safety Study
2. PTC Therapeutics Appoints Mark Rothera As Chief Commercial Officer
3. DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
4. Serina Therapeutics Announces Agreement Retaining Woodside Capital Partners as Advisor and Investment Bank
5. Serina Therapeutics Announces Worldwide Exclusive License Agreement with The Scripps Research Institute for Click Chemistry
6. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
7. Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress
8. Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
9. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
10. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
11. Spencer Trask Congratulates InVivo Therapeutics on its Recent Approvals from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... YORK , Sept. 2, 2015 About ... is a malignant condition characterized by increased production of ... affects B-lymphocytes and then it can spread to other ... at later stages because of the slow buildup of ... the malignancy spreads to the spleen, liver, and lymph ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ... Affairs in China (Basel, Switzerland - November 26-27, 2015)" ... provide a detailed overview of the key areas of pharmaceutical ... Hong Kong , Macau and ... - All important aspects of gaining and maintaining a ...
(Date:9/2/2015)... Miss. , Sept. 2, 2015   Gulf Coast Tattoo ... removal services with the cutting-edge Astanza Duality laser in ... unwanted ink erase their tattoo regret and take back control of ... but extends its services to Biloxi ... region. "With tattoo regret being as prevalent as it ...
Breaking Medicine Technology:Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2
... ALTO, Calif., April 25, 2012  Varian Medical Systems (NYSE: ... quarter of fiscal year 2012 with net earnings of $0.94 ... share in the second quarter of fiscal year 2011.  The ... a $2.5 million or $0.02 per diluted share restructuring charge ...
... AKRON, Ohio, April 25, 2012  Researchers, health care ... for the inaugural National Conference on Value-driven Engineering ... assembled by the Austen BioInnovation Institute in Akron ... Foundation. Experts from some of the nation,s leading ...
Cached Medicine Technology:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 2Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 3Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 4Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 5Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 6Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 7Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 8Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering 2Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering 3Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering 4
(Date:9/3/2015)... , ... September 03, 2015 , ... At Renew Man™, ... dissatisfied with the traditional health care model, where the primary care physician dictates and ... who want to become educated about their health issues and empowered to choose their ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... Bob Anders and Kelley Chapman will be joining the company’s executive leadership team ... Anders has over 30 years’ experience in healthcare product and project management. He ...
(Date:9/2/2015)... ... September 03, 2015 , ... Leah ... among the most influential leaders in healthcare, will offer the keynote address at ... place October 15-16, 2015, in Palm Harbor, Florida, at the Innisbrook Resort and ...
(Date:9/2/2015)... ... ... Chris Harrison of Harrison’s Footwear of Poulsbo announces the launch of his ... “We have a lot of repeat customers, and many of them drive quite a ... given them the convenience of ordering from home.” , Harrison’s Footwear has gained a ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Telehealth represents ... Well Corp., contracted to handle the telehealth services of more than 12 Blues plan ... and Blue Shield Plans takes a look this growing trend, interviewing executives at Capital ...
Breaking Medicine News(10 mins):Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 2Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 3Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:Harrison's Comfort Footwear Announces Expansion with New CHarrison Online Store 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3
... had today undergone treatment at the All India Institute of ... to him explained that Gogoi, who had returned to India ... taken to AIIMS as he had complained of uneasiness. ... said that he was suffering from dehydration. The Chief Minister ...
... Zanzibar, a semi-autonomous island in Tanzania have multiplied ... to control the outbreak //of bird flu on the island. ... into Zanzibar from mainland Tanzania, were destroyed last ... of them were facing prosecution after they failed to ...
... From the research results of Dr Andrew Wakefield, their seems to ... autism related bowel // diseases – Lancet published in 1998 says. ... the MMR vaccinated children need to face a charge of professional ... people revealed nearly 92% of children in the year 1995-96 and ...
... is found that the survival rate of Hodgkin’s disease (HD) ... the study were published in the journal Cancer. //It revealed ... the best prognosis. There were significant differences existed between the ... of the lymphatic system of the body, which includes lymph ...
... people have succumbed to AIDS in Sagar district of Madhya Pradesh ... ,Of the 53 infected with the Human Immunodeficiency Virus (HIV) ... of full blown AIDS, including one woman, 16 men and two ... were detected in the district in March, 10 HIV cases came ...
... Organization said on Monday that it was setting up ... Chinese government //in fighting diseases like severe acute respiratory ... joint statement from the WHO and China's Ministry of ... Tuesday at the Center for Disease Control and Prevention ...
Cached Medicine News:Health News:HD Type Plays an Important Role in the Survival of the Patient 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: